Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Blarcamesine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anavex Life Sciences Updates EU Regulatory Review
    Anavex Life Sciences Updates EU Regulatory Review

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262094/29248/en/Anavex-Life-Sciences-Provides-Update-on-Regulatory-Review-in-the-EU-for-Blarcamesine-to-Treat-Early-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Anavex Life Presents New Data from its AD-004 Phase IIb/III Trial
    Anavex Life Presents New Data from its AD-004 Phase IIb/III Trial

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260284/29248/en/Anavex-Life-Sciences-Presents-New-Data-from-its-AD-004-Phase-IIb-III-Trial-at-AD-PD-2026-Conference-Demonstrating-Consistent-Correlation-Between-the-Treatment-Effect-of-Oral-Blarca.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Anavex Shows Blarcamesine Effects In PD Model At ADPD 2026
    Anavex Shows Blarcamesine Effects In PD Model At ADPD 2026

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257034/29248/en/Anavex-Life-Sciences-Presents-Significant-Treatment-Effects-of-Blarcamesine-in-New-Advanced-Alpha-Synuclein-Model-of-Parkinson-s-Disease-at-AD-PD-2026-Conference.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Anavex Life Sciences Unveils Q1 2026 Financials And Business
    Anavex Life Sciences Unveils Q1 2026 Financials And Business

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234426/29248/en/Anavex-Life-Sciences-Reports-Fiscal-2026-First-Quarter-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Anavex Seeks EMA Re-Examination of Blarcamesine Ruling
    Anavex Seeks EMA Re-Examination of Blarcamesine Ruling

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207608/29248/en/Anavex-Life-Sciences-Submitted-Request-for-EMA-to-Re-Examine-Its-Opinion.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Anavex Provide Update on Regulatory Review in EU for Blarcamesine
    Anavex Provide Update on Regulatory Review in EU for Blarcamesine

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204857/29248/en/Anavex-Life-Sciences-Provides-Update-on-Regulatory-Review-in-the-EU-for-Blarcamesine-to-Treat-Early-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.